US biotech Annovis Bio has reported encouraging findings for its experimental therapy buntanetap in a subgroup of patients ...

Swiss biopharma Idorsia (SIX: IDIA) has received approval from the US Food and Drug Administration for an updated label on ...

US biotech Cartesian Therapeutics has reported that patients with generalized myasthenia gravis (gMG) continued to experience ...

US pharma major Bristol Myers Squibb has received full approval from the US Food and Drug Administration for the use of ...

US clinical-stage rare diseases focused Rallybio Corporation (Nasdaq: RLYB) says it will discontinue the development of its ...

For more than four decades since the passage of the Hatch-Waxman Act, the US generic drug market has provided patients with ...

Shares of USA and UK-based KalVista Pharmaceuticals (Nasdaq: KALV) fell 4% to $11.04 yesterday, despite the company revealing it has signed a licensing deal for the commercialization rights in Japan ...

Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...

The uveitis treatment market across seven major economies—the USA, France, Germany, Italy, Spain, the UK, and Japan—is ...

In the USA, the layoffs at health agencies, proposed tariffs on imports and other disruptive policies under President Donald ...

Myricx Bio, a UK biotech focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates ...

A federal commission has urged the US government to invest $15 billion to protect the country’s leadership in biotechnology and prevent China from outpacing American innovation in the field. The ...